Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 1, 2014, Pages 194-206

  Wang, Ning ^a   Wang, Ting ^b,c   Zhang, Meiling ^b   Chen, Ruonan ^b   Niu, Ruowen ^b   Deng, Yihui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c JINING MEDICAL UNIVERSITY   (China)

Author keywords

Cold chain; Immune response; Lyophilization; Mucosa associated lymphoid tissue; Pathogen associated molecular pattern; Vaccine adjuvant delivery system

Indexed keywords

BOVINE SERUM ALBUMIN; EMULSIFYING AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; LIPID A; LIPOSOME; MACROGOL 10000; MANNOSE; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHORYL LIPID A; SUBUNIT VACCINE; SUCROSE; CATION; CHOLESTEROL; CYTOKINE; EMULSION; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; LIPID; MACROGOL DERIVATIVE; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONJUGATE; DRUG DELIVERY SYSTEM; EMULSION; FEMALE; FREEZE DRYING; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTESTINAL SECRETIONS; LECTIN BINDING; MOUSE; NONHUMAN; VAGINAL SECRETION; ANIMAL; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; LYMPHOCYTE; METABOLISM; MOUTH MUCOSA; MUCOSA; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHAGOCYTOSIS; SPLEEN; TEMPERATURE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; CATIONS; CELL SURVIVAL; CHOLESTEROL; CYTOKINES; EMULSIONS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LIPID A; LIPIDS; LIPOSOMES; LYMPHOCYTES; MANNOSE; MICE; MOUTH MUCOSA; MUCOUS MEMBRANE; PHAGOCYTOSIS; POLYETHYLENE GLYCOLS; SERUM ALBUMIN, BOVINE; SPLEEN; TEMPERATURE; VACCINES;

EID: 84934293756     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.04.007     Document Type: Article

References (54)

1. Ozawa, S., Mirelman, A., Stack, M.L., Walker, D.G., Levine, O.S., Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine 31 (2012), 96–108.
2. Levine, M.M., “IDEAL” vaccines for resource poor settings. Vaccine, 29(Suppl 4), 2011 D116-125.
3. Chen, D., Zehrung, D., Desirable attributes of vaccines for deployment in low-resource settings. J Pharm Sci 102 (2012), 29–33.
4. Campo, J.D., Zayas, C., Romeu, B., Acevedo, R., Gonzalez, E., Bracho, G., Cuello, M., Cabrera, O., Balboa, J., Lastre, M., Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. Methods 49 (2009), 301–308.
5. Yuki, Y., Kiyono, H., Mucosal vaccines: novel advances in technology and delivery. Expert Rev Vaccines 8 (2009), 1083–1097.
6. Lycke, N., Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 12 (2012), 592–605.
7. Gebril, A., Alsaadi, M., Acevedo, R., Mullen, A.B., Ferro, V.A., Optimizing efficacy of mucosal vaccines. Expert Rev Vaccines 11 (2012), 1139–1155.
8. Wang, L., Coppel, R.L., Oral vaccine delivery: can it protect against non-mucosal pathogens?. Expert Rev Vaccines 7 (2008), 729–738.
9. Zaman, M., Chandrudu, S., Toth, I., Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res 3 (2013), 100–109.
10. Tonnis, W.F., Lexmond, A.J., Frijlink, H.W., de Boer, A.H., Hinrichs, W., Devices and formulations for pulmonary vaccination. Expert Opin Drug Deliv 10 (2013), 1383–1397.
11. Holmgren, J., Czerkinsky, C., Eriksson, K., Mharandi, A., Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine, 21(Suppl 2), 2003 pp. S89-95.
12. Khatri, K., Goyal, A.K., Gupta, P.N., Mishra, N., Mehta, A., Vyas, S.P., Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine 26 (2008), 2225–2233.
13. Cutler, C.W., Jotwani, R., Dendritic cells at the oral mucosal interface. J Dent Res 85 (2006), 678–689.
14. Kim, S.H., Lee, K.Y., Jang, Y.S., Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination. Immune Netw 12 (2012), 165–175.
15. Moyle, P.M., Toth, I., Modern subunit vaccines: development, components, and research opportunities. ChemMedChem 8 (2013), 360–376.
16. Pham, T.T., Barratt, G., Michel, J.P., Loiseau, P.M., Saint-Pierre-Chazalet, M., Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates. Colloids Surf B Biointerfaces 106 (2013), 224–233.
17. Plotkin, S.A., Vaccines: past, present and future. Nat Med, 11, 2005 pp. S5-11.
18. Moyle, P.M., McGeary, R.P., Blanchfield, J.T., Toth, I., Mucosal immunisation: adjuvants and delivery systems. Curr Drug Deliv 1 (2004), 385–396.
19. Schijns, V.E., Lavelle, E.C., Trends in vaccine adjuvants. Expert Rev Vaccines 10 (2011), 539–550.
20. O'Hehir, R.E., Sandrini, A., Anderson, G.P., Rolland, J.M., Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation. Curr Med Chem 14 (2007), 2235–2244.
21. Kweon, M.N., Sublingual mucosa: A new vaccination route for systemic and mucosal immunity. Cytokine 54 (2011), 1–5.
22. Alving, C.R., Rao, M., Steers, N.J., Matyas, G.R., Mayorov, A.V., Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines. Expert Rev Vaccines 11 (2012), 733–744.
23. Irache, J.M., Salman, H.H., Gamazo, C., Espuelas, S., Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv 5 (2008), 703–724.
24. Carrion, C., Domingo, J.C., de Madariaga, M.A., Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. Chem Phys Lipids 113 (2001), 97–110.
25. Muthiah, M., Vu-Quang, H., Kim, Y.K., Rhee, J.H., Kang, S.H., Jun, S.Y., Choi, Y.J., Jeong, Y.Y., Cho, C.S., Park, I.K., Mannose-poly(ethylene glycol)-linked SPION targeted to antigen presenting cells for magnetic resonance imaging on lymph node. Carbohydr Polym 92 (2013), 1586–1595.
26. Wang, T., Wang, N., Jin, X., Zhang, K., Li, T., A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions. J Liposome Res 19 (2009), 231–240.
27. Wang, T., Wang, N., Song, H., Xi, X., Wang, J., Hao, A., Li, T., Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine. Eur J Pharm Sci 44 (2011), 127–135.
28. Wang, T., Wang, N., Sun, W., Li, T., Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions. Chem Phys Lipids 164 (2011), 151–157.
29. Wang, T., Deng, Y., Geng, Y., Gao, Z., Zou, J., Wang, Z., Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. Biochim Biophys Acta 1758 (2006), 222–231.
30. Fiske, C.H., Subbarow, Y., The colorimetric determination of phosphorous. J Biol Chem 66 (1925), 375–400.
31. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976), 248–254.
32. Udenfriend, S., Stein, S., Bohlen, P., Dairman, W., Leimgruber, W., Weigele, M., Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178 (1972), 871–872.
33. Guo, L., Chen, J., Qiu, Y., Zhang, S., Xu, B., Gao, Y., Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. Int J Pharm 447 (2013), 22–30.
34. Clark, J.D., Baldwin, R.L., Bayne, K.A., Brown, M.J., Gebhart, G.F., Gonder, J.C., Gwathmey, J.K., Keeling, M.E., Kohn, D.F., Robb, J.W., Smith, O.A., Steggerda, J.A.D., Vandenbergh, J.G., White, W.J., Williams-Blangero, S., VandeBerg, J.L., Guide for the Care and Use of Laboratory Animals. 1996, National Academy Press, Washington, D.C.
35. Festing, M.F., Altman, D.G., Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 43 (2002), 244–258.
36. Frey, A., Meckelein, B., Externest, D., Schmidt, M.A., A stable and highly sensitive 3,3’,5,5’-tetramethylbenzidine-based substrate reagent for enzyme-linked immunosorbent assays. J Immunol Methods 233 (2000), 47–56.
37. Zarif, L., Drug delivery by lipid cochleates. Methods Enzymol 391 (2005), 314–329.
38. Fishman, M.A., Perelson, A.S., Th1/Th2 differentiation and cross-regulation. Bull Math Biol 61 (1999), 403–436.
39. Ge, S., Kojio, K., Takahara, A., Kajiyama, T., Bovine serum albumin adsorption onto immobilized organotrichlorosilane surface. influence of the phase separation on protein adsorption patterns. J Biomater Sci Polym Ed 9 (1998), 131–150.
40. Lee, B.Y., Cakouros, B.E., Assi, T.M., Connor, D.L., Welling, J., Kone, S., Djibo, A., Wateska, A.R., Pierre, L., Brown, S.T., The impact of making vaccines thermostable in Niger's vaccine supply chain. Vaccine 30 (2012), 5637–5643.
41. Pastor, M., Esquisabel, A., Talavera, A., Ano, G., Fernandez, S., Cedre, B., Infante, J.F., Callico, A., Pedraz, J.L., An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles. Int J Pharm 448 (2013), 247–258.
42. Carey, J.B., Pearson, F.E., Vrdoljak, A., McGrath, M.G., Crean, A.M., Walsh, P.T., Doody, T., O'Mahony, C., Hill, A.V., Moore, A.C., Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice. PLoS One, 6, 2013, e22442.
43. Nochi, T., Takagi, H., Yuki, Y., Yang, L., Masumura, T., Mejima, M., Nakanishi, U., Matsumura, A., Uozumi, A., Hiroi, T., Morita, S., Tanaka, K., Takaiwa, F., Kiyono, H., Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A 104 (2007), 10986–10991.
44. Wang, S.H., Kirwan, S.M., Abraham, S.N., Staats, H.F., Hickey, A.J., Stable dry powder formulation for nasal delivery of anthrax vaccine. J Pharm Sci 101 (2012), 31–47.
45. Giannola, L.I., Sutera, F.M., De Caro, V., Physical methods to promote drug delivery on mucosal tissues of the oral cavity. Expert Opin Drug Deliv 10 (2013), 1449–1462.
46. Kim, S.H., Kim, J.Y., Choi, Y., Nguyen, H.H., Song, M.K., Chang, J., Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection. PLoS One, 8, 2013, e75460.
47. Mann, J.F., Acevedo, R., Campo, J.D., Perez, O., Ferro, V.A., Delivery systems: a vaccine strategy for overcoming mucosal tolerance?. Expert Rev Vaccines 8 (2009), 103–112.
48. Mestecky, J., Russell, M.W., Elson, C.O., Perspectives on mucosal vaccines: is mucosal tolerance a barrier?. J Immunol 179 (2007), 5633–5638.
49. Bevan, M.J., Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143 (1976), 1283–1288.
50. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., Rock, K.L., Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A 90 (1993), 4942–4946.
51. Vyas, J.M., Van der Veen, A.G., Ploegh, H.L., The known unknowns of antigen processing and presentation. Nat Rev Immunol 8 (2008), 607–618.
52. Shen, H., Ackerman, A.L., Cody, V., Giodini, A., Hinson, E.R., Cresswell, P., Edelson, R.L., Saltzman, W.M., Hanlon, D.J., Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 117 (2006), 78–88.
53. Casella, C.R., Mitchell, T.C., Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci 65 (2008), 3231–3240.
54. Mata-Haro, V., Cekic, C., Martin, M., Chilton, P.M., Casella, C.R., Mitchell, T.C., The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316 (2007), 1628–1632.